INGENUITY SYSTEMS INC
Redwood City, CA · CIK 0001121620 · Biotech · Acquired
Bioinformatics software platform for analyzing genomic and clinical data to generate actionable insights
digitalinsights.qiagen.com →- Grants
- $398K
- 3 awards
- Sector median: 1
- Raised
- $15M
- 1 Form D · Jul 2010
- 195 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 1 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓1999200120032005200720092011
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Genenet-a Knowledge Base Of Functional Genetic Data | $201,880 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Functional Clustering Approach To Genomic Analysis | $65,428 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Functional Clustering Approach To Genomic Analysis | $130,852 | |
| Private capital raised | Form D · SEC | $15,399,233 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2476 | Surf Bio, Inc. | — | $16M |
| 2477 | ImmunGene | — | — |
| 2478 | MABVAX THERAPEUTICS INC | — | $16M |
| 2479 | INGENUITY SYSTEMS INC | — | $15M |
| 2480 | MANHATTAN PHARMACEUTICALS INC | — | $14M |
| 2481 | CORNERSTONE PHARMACEUTICALS INC | — | $13M |
| 2482 | DMC Limited | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- John DiekmanDirector
- Jacob LeschlyDirector · Executive Officer
- Daniel ShiffmanExecutive Officer
- Jim SwartzDirector
- Mark WanDirector
- Michael WardDirector
Patents
- Constructing And Maintaining A Computerized Knowledge Representation System Using Fact Templatesgranted
- Methods And Systems For Identification Of Causal Genomic Variantsapplication
- Methods And Systems For Biological Data Analysisapplication
- Genomics Based Targeted Advertisingapplication
- Drug Discovery Methodsapplication
- Method And System For Performing Information Extraction And Quality Control For A Knowledge Baseapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.